Standout Papers

Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the ... 1993 2026 2004 2015 1.2k
  1. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients (1993)
    E. P. Krenning, Dik J. Kwekkeboom et al. European Journal of Nuclear Medicine and Molecular Imaging

Immediate Impact

13 by Nobel laureates 1 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Recent Advances in Contrast-Enhanced Photoacoustic Imaging: Overcoming the Physical and Practical Challenges
2023 Standout
2 intermediate papers

Works of P.T.E. Postema being referenced

Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
1993 Standout

Author Peers

Author Last Decade Papers Cites
P.T.E. Postema 1309 325 93 964 853 10 1.7k
M. van Hagen 1020 228 51 732 657 4 1.4k
D. J. Kwekkeboom 981 319 23 716 539 33 1.5k
Christian Waldherr 908 104 65 883 559 23 1.8k
Kjell E. Öberg 1363 153 64 1293 975 34 2.1k
Klaus‐Jochen Klose 1935 121 36 1756 1498 18 2.2k
Raffaella Barone 891 53 32 753 523 22 1.4k
Jörg Schmitt 994 132 6 790 529 10 1.3k
Ulrike Garske‐Román 638 63 10 661 403 18 1.2k
Michael Bläker 1786 151 35 1650 1298 26 2.2k
Esther Alfandary 387 168 75 204 204 11 1.2k

All Works

Loading papers...

Rankless by CCL
2026